Napp Pharmaceuticals has won a temporary reprieve from having to comply with an Office of Fair Trading order to cease anti-competitive practices. In March, Napp was the first company to be fined under the Competition Act 1998 for supplying a morphine product to patients at excessively high prices while discounting the product to hospitals. The company has...